Np mrd loader

Record Information
Version2.0
Created at2022-09-04 21:55:30 UTC
Updated at2022-09-04 21:55:30 UTC
NP-MRD IDNP0202665
Secondary Accession NumbersNone
Natural Product Identification
Common Name(2e,4e,6e)-7-[(1r,2s,6s)-4-{[(2e,4e,6e)-7-cyclohexyl-1-hydroxyhepta-2,4,6-trien-1-ylidene]amino}-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl]-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)hepta-2,4,6-trienimidic acid
DescriptionAsukamycin, also known as AM 1042, belongs to the class of organic compounds known as cyclohexenones. Cyclohexenones are compounds containing a cylohexenone moiety, which is a six-membered aliphatic ring that carries a ketone and has one endocyclic double bond. Thus, asukamycin is considered to be a fatty amide. Asukamycin is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. (2e,4e,6e)-7-[(1r,2s,6s)-4-{[(2e,4e,6e)-7-cyclohexyl-1-hydroxyhepta-2,4,6-trien-1-ylidene]amino}-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl]-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)hepta-2,4,6-trienimidic acid is found in Apis cerana, Streptomyces nodosus and Streptomyces nodosus. (2e,4e,6e)-7-[(1r,2s,6s)-4-{[(2e,4e,6e)-7-cyclohexyl-1-hydroxyhepta-2,4,6-trien-1-ylidene]amino}-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl]-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)hepta-2,4,6-trienimidic acid was first documented in 1986 (PMID: 3553432). Based on a literature review a significant number of articles have been published on asukamycin (PMID: 24838618) (PMID: 32344935) (PMID: 35218125) (PMID: 30696899) (PMID: 20522559) (PMID: 23995809).
Structure
Thumb
Synonyms
ValueSource
AM 1042ChEBI
Asukamycin a1ChEBI
Chemical FormulaC31H34N2O7
Average Mass546.6200 Da
Monoisotopic Mass546.23660 Da
IUPAC Name(2E,4E,6E)-7-[(1R,2S,6S)-4-{[(2E,4E,6E)-7-cyclohexyl-1-hydroxyhepta-2,4,6-trien-1-ylidene]amino}-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl]-N-(2-hydroxy-5-oxocyclopent-1-en-1-yl)hepta-2,4,6-trienimidic acid
Traditional Nameasukamycin
CAS Registry NumberNot Available
SMILES
OC(\C=C\C=C\C=C\[C@]1(O)C=C(N=C(O)\C=C\C=C\C=C\C2CCCCC2)C(=O)[C@H]2O[C@@H]12)=NC1=C(O)CCC1=O
InChI Identifier
InChI=1S/C31H34N2O7/c34-23-17-18-24(35)27(23)33-26(37)16-10-3-4-11-19-31(39)20-22(28(38)29-30(31)40-29)32-25(36)15-9-2-1-6-12-21-13-7-5-8-14-21/h1-4,6,9-12,15-16,19-21,29-30,34,39H,5,7-8,13-14,17-18H2,(H,32,36)(H,33,37)/b2-1+,4-3+,12-6+,15-9+,16-10+,19-11+/t29-,30-,31+/m1/s1
InChI KeySSHVAUUEPNULMP-JHWDTTIQSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Apis ceranaLOTUS Database
Streptomyces nodosusLOTUS Database
Streptomyces nodosus subsp. asukaensisLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as cyclohexenones. Cyclohexenones are compounds containing a cylohexenone moiety, which is a six-membered aliphatic ring that carries a ketone and has one endocyclic double bond.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbonyl compounds
Direct ParentCyclohexenones
Alternative Parents
Substituents
  • Cyclohexenone
  • N-acyl-amine
  • Tertiary alcohol
  • Vinylogous acid
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Carboxylic acid derivative
  • Dialkyl ether
  • Oxirane
  • Ether
  • Oxacycle
  • Organoheterocyclic compound
  • Alcohol
  • Organopnictogen compound
  • Organonitrogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Aliphatic heteropolycyclic compound
Molecular FrameworkAliphatic heteropolycyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP4.12ChemAxon
pKa (Strongest Acidic)5.54ChemAxon
pKa (Strongest Basic)2.01ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count9ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area152.31 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity160.33 m³·mol⁻¹ChemAxon
Polarizability60.76 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00018105
Chemspider ID4945243
KEGG Compound IDC12099
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound6441014
PDB IDNot Available
ChEBI ID73481
Good Scents IDNot Available
References
General References
  1. Petrickova K, Pospisil S, Kuzma M, Tylova T, Jagr M, Tomek P, Chronakova A, Brabcova E, Andera L, Kristufek V, Petricek M: Biosynthesis of colabomycin E, a new manumycin-family metabolite, involves an unusual chain-length factor. Chembiochem. 2014 Jun 16;15(9):1334-45. doi: 10.1002/cbic.201400068. Epub 2014 May 18. [PubMed:24838618 ]
  2. Hrdy J, Sukenikova L, Petraskova P, Novotna O, Kahoun D, Petricek M, Chronakova A, Petrickova K: Inhibition of Pro-Inflammatory Cytokines by Metabolites of Streptomycetes-A Potential Alternative to Current Anti-Inflammatory Drugs? Microorganisms. 2020 Apr 25;8(5). pii: microorganisms8050621. doi: 10.3390/microorganisms8050621. [PubMed:32344935 ]
  3. Yan X, Zhang J, Tan H, Liu Z, Jiang K, Tian W, Zheng M, Lin Z, Deng Z, Qu X: A Pair of Atypical KAS III Homologues with Initiation and Elongation Functions Program the Polyketide Biosynthesis in Asukamycin. Angew Chem Int Ed Engl. 2022 May 2;61(19):e202200879. doi: 10.1002/anie.202200879. Epub 2022 Mar 10. [PubMed:35218125 ]
  4. Hu D, Gao C, Sun C, Jin T, Fan G, Mok KM, Lee SM: Genome-guided and mass spectrometry investigation of natural products produced by a potential new actinobacterial strain isolated from a mangrove ecosystem in Futian, Shenzhen, China. Sci Rep. 2019 Jan 29;9(1):823. doi: 10.1038/s41598-018-37475-w. [PubMed:30696899 ]
  5. Rui Z, Petrickova K, Skanta F, Pospisil S, Yang Y, Chen CY, Tsai SF, Floss HG, Petricek M, Yu TW: Biochemical and genetic insights into asukamycin biosynthesis. J Biol Chem. 2010 Aug 6;285(32):24915-24. doi: 10.1074/jbc.M110.128850. Epub 2010 Jun 3. [PubMed:20522559 ]
  6. Ito T: [Biosynthetic study of actinomycetes-metabolites for creating novel analogs]. Yakugaku Zasshi. 2013;133(9):1007-15. doi: 10.1248/yakushi.13-00175. [PubMed:23995809 ]
  7. Rui Z, Sandy M, Jung B, Zhang W: Tandem enzymatic oxygenations in biosynthesis of epoxyquinone pharmacophore of manumycin-type metabolites. Chem Biol. 2013 Jul 25;20(7):879-87. doi: 10.1016/j.chembiol.2013.05.006. [PubMed:23890006 ]
  8. Bai L: Tandem modifications of an epoxyquinone C7N pharmacophore. Chem Biol. 2013 Jul 25;20(7):859-60. doi: 10.1016/j.chembiol.2013.07.003. [PubMed:23890003 ]
  9. Xie P, Sheng Y, Ito T, Mahmud T: Transcriptional regulation and increased production of asukamycin in engineered Streptomyces nodosus subsp. asukaensis strains. Appl Microbiol Biotechnol. 2012 Oct;96(2):451-60. doi: 10.1007/s00253-012-4084-2. Epub 2012 May 5. [PubMed:22555913 ]
  10. Pospisil S, Petrickova K, Sedmera P, Halada P, Olsovska J, Petricek M: Effect of starter unit availability on the spectrum of manumycin-type metabolites produced by Streptomyces nodosus ssp. asukaensis. J Appl Microbiol. 2011 Nov;111(5):1116-28. doi: 10.1111/j.1365-2672.2011.05132.x. Epub 2011 Sep 8. [PubMed:21854515 ]
  11. Shipley PR, Donnelly CC, Le CH, Bernauer AD, Klegeris A: Antitumor activity of asukamycin, a secondary metabolite from the actinomycete bacterium Streptomyces nodosus subspecies asukaensis. Int J Mol Med. 2009 Nov;24(5):711-5. doi: 10.3892/ijmm_00000283. [PubMed:19787206 ]
  12. Petricek M, Petrickova K, Havlicek L, Felsberg J: Occurrence of two 5-aminolevulinate biosynthetic pathways in Streptomyces nodosus subsp. asukaensis is linked with the production of asukamycin. J Bacteriol. 2006 Jul;188(14):5113-23. doi: 10.1128/JB.01919-05. [PubMed:16816183 ]
  13. Hu Y, Floss HG: Further studies on the biosynthesis of the manumycin-type antibiotic, asukamycin, and the chemical synthesis of protoasukamycin. J Am Chem Soc. 2004 Mar 31;126(12):3837-44. doi: 10.1021/ja039336+. [PubMed:15038738 ]
  14. Floss HG, Keller PJ, Beale JM: Studies on the biosynthesis of antibiotics. J Nat Prod. 1986 Nov-Dec;49(6):957-70. doi: 10.1021/np50048a001. [PubMed:3553432 ]
  15. LOTUS database [Link]